AP NEWS

Global Healthcare-Acquired Infection Market Report 2017-2023: Devices, Pharmaceuticals, and Environmental Products - ResearchAndMarkets.com

October 4, 2018

DUBLIN--(BUSINESS WIRE)--Oct 4, 2018--The “Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products” report has been added to ResearchAndMarkets.com’s offering.

The report focuses on select drugs (antimicrobials), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (e.g. catheters, patient ventilation devices, sterile IV filters) that prevent occurrence of nosocomial infections.

Within each type of treatment, regional analyses will focus on the Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa) and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).

The Report Includes:

42 data tables and 32 additional tables Industry analysis of the global healthcare-acquired infection (HCAI) control market Detailed overview and trend analysis of pharmaceutical treatment (antimicrobials and vaccines), environment treatment (disinfectants, sterilization systems etc.) and provisions in medical devices (catheters, patient ventilation devices, sterile intravenous [IV] filters) that prevent these infections Analyses of global market trends with data from 2017, estimates for 2018 and projections of compound annual growth rates (CAGRs) through 2023 Emphasis on selected devices, pharmaceuticals and environmental products currently employed or under development for treatment of viral, bacterial and fungal infections Analysis of antimicrobial resistance and more specifically antibiotic resistance as a cause for these infections A look at the hospital surveillance methods and tools currently being used to prevent these infections Regional analysis of the market covering Americas (i.e. Canada, the U.S., Mexico, Central America and South America), EMRA (i.e. Europe, the Middle East, Russia and Africa); and Asia-Pacific (i.e. Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries) Information on key patents and newer research developments in sterilization systems and devices Examination of vendor landscape and profiles of key players in the HCAI market, including Novartis, Pfizer, Roche, 3M Healthcare and Sanofi Pasteur

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary And Highlights

Chapter 3 Overview

Chapter 4 Market Summary And Analysis

Chapter 5 Pharmaceuticals

Chapter 6 Environmental Treatment

Chapter 7 Medical Devices

Chapter 8 Industry Structure

Chapter 9 Research And Opportunities

Chapter 10 Patent Analysis

Chapter 11 Company Profiles

Pharmaceutical Companies Gilead Sciences Merck Novartis Pfizer Roche Sanofi, Sanofi Pasteur Seqirus Companies In Sterilization/Disinfection Industry 3M Healthcare Advanced Sterilization Products Becton, Dickinson And Company Belimed Sterigenics The Clorox Company Xenex Disinfection Services Medical Device Companies Bactiguard Teleflex

For more information about this report visit https://www.researchandmarkets.com/research/4phghl/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181004005234/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices,Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/04/2018 04:13 AM/DISC: 10/04/2018 04:13 AM

http://www.businesswire.com/news/home/20181004005234/en

AP RADIO
Update hourly